FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus (COVID-19), in Cambridge, Massachusetts, USA, May 18, 2020. REUTERS / Brian Snyder (Reuters) – Drug Developer Moderna Inc (MRNA.O) on Friday said it has so far enrolled 13,194 participants in the ongoing 30,000-volunteer …
Read More »
(Reuters) – The following is a roundup of some of the latest scientific studies on the new coronavirus and efforts to find treatments and vaccines for COVID-19, the disease caused by the virus. New questions about inhibitor COVID-19 efficacy A new study raises fresh questions about the effectiveness of Gilead …
Read More »
FILE PHOTO: A man walks past a sign outside Pfizer headquarters in the source of Manhattan in New York City, New York, USA, July 22, 2020. REUTERS / Carlo Allegri / File Photo (Reuters) – Shares of Pfizer Inc and US-listed shares of partner BioNTech SE rose on Friday after …
Read More »
LONDON (Reuters) – Russia’s plan to roll out its “Sputnik-V” COVID-19 vaccine, even before full studies show how well it works, requires concern among virus experts, who warn of a partially effective shot at the new encourage coronavirus to mutate. PHILO PHOTO: A handout photo provided by the Russian Direct …
Read More »
(Reuters) – A US government program that compensates people who say they are harmed by an emergency vaccine has paid out on less than 10% of claims, raising questions about whether the process should be used to deal with any side effects from a coronavirus shot to sue, according to …
Read More »